Advertisement

Neoadjuvant Treatment for Squamous Carcinoma of the Thoracic Esophagus

  • Ernesto Laterza
  • Ugo S. Urso
  • Giovanni De’ Manzoni
  • Claudio Cordiano
Conference paper

Abstract

Cancer of the esophagus has a poor prognosis. Survival rates appear to be correlated with depth of tumor invasion (T), lymph node involvement (N) and the presence of distant metastases (M). The biological behavior of the disease, characterized by early regional lymphatic spread, make it a systemic disease and explains the poor results of surgery and radiotherapy. In the last 20 years, survival rates for esophageal cancer have been less than 10% [1–2]. To obtain better results, several authors suggested many trials of different treatments including chemotherapy.

Keywords

Esophageal Cancer Esophageal Squamous Cell Carcinoma Esophageal Carcinoma Squamous Carcinoma Thoracic Esophagus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Earlam R, Cunha-Melo JR (1980) Esophageal squamous cell carcinoma. A critical review of radiotherapy. Br J Surg 67: 457–61PubMedCrossRefGoogle Scholar
  2. 2.
    Launois B, Delarue D, Campion JP (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153: 690–2PubMedGoogle Scholar
  3. 3.
    Kelsen DP, Bains M, Hilaris B (1981) Cisplatin-based preoperative chemotherapy of esophageal carcinoma in adjuvant therapy of cancer. In: Salomon S, Jones (eds) Grune and Stratton, New York, pp 495–502Google Scholar
  4. 4.
    Steiger Z, Franklin R, Wilson R (1981) Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy and surgical therapy. J Thorac Cardiovasc Surg 82: 713PubMedGoogle Scholar
  5. 5.
    Herskovic A, Leichman L, Lattin P (1988) Chemo/radiation with and without surgery in the thoracic esophagus: The Wayne State Experience. Int J Rad Oncol Biol Phis 15: 655–662CrossRefGoogle Scholar
  6. 6.
    Japanese Committee for Registration of Esophageal Carcinoma (1985) A proposal for a new TNM classification of esophageal carcinoma. Jpn J Clin Oncol 14: 655–662Google Scholar
  7. 7.
    Popp MB, Hawley D, Reiseng J (1986) Improved survival in squamous esophageal cancer. Arch Surg 121: 1330–5PubMedCrossRefGoogle Scholar
  8. 8.
    Austin JC, Postier RG, Elkins RC (1986) Treatment of esophageal cancer: The continued need for surgical resection. Am J Surg 152: 592–596PubMedCrossRefGoogle Scholar
  9. 9.
    Orringer MB, Forastiere AA, Perez-Tamayo C (1990) Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg 49: 348–55PubMedCrossRefGoogle Scholar
  10. 10.
    Lackey VL, Reagan MT, Smith RA (1989) Neoadjuvant therapy of squamous cell carcinoma: Role of resection and benefit in partial responders. Ann Thorac Surg 48: 218–221PubMedCrossRefGoogle Scholar
  11. 11.
    Hilgenberg AD, Carey RW, Wilkins EW, Choi NC, Mathinsen DJ, Grillo HC (1988) Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 45: 357–6PubMedCrossRefGoogle Scholar
  12. 12.
    McFarlane SD, Lucius DH, Jolly PC, Kozarek RA, Anderson RP (1988) Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after preoperative combined chemotherapy and radiation. J Thorac Cardiovasc Surg 95: 415–22Google Scholar
  13. 13.
    Parker EF, Carolyn ER (1989) Chemotherapy, radiation therapy, and resection for carcinoma of the esophagus. J Thorac Cardiovasc Surg 98: 1037–44PubMedGoogle Scholar
  14. 14.
    Poplin E, Fleming T, Leichman L (1987) Combined therapies for squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 5: 622–628PubMedGoogle Scholar
  15. 15.
    Peracchia A, Debesi B, Castoro C (1989) Results of surgery after cisplatin and 5-fluorouracil combination chemotherapy for locally advanced esophageal squamous cell carcinoma. Fourth world congress of the International Society for Diseases of the Esophagus. Chicago, SeptemberGoogle Scholar
  16. 16.
    Campbell WR, Taylor SA, Pierce GE, Hermrelk AS, Thomas JH (1985) Therapeutic alternative in patients with esophageal cancer. Annual meeting Southwestern Surgical Congress, Las Vegas, AprilGoogle Scholar
  17. 17.
    Leichman L, Berry BT (1991) Experience with cisplatin in treatment regimens for esophageal cancer. Semin Oncol 18: 64–72PubMedGoogle Scholar
  18. 18.
    Stewart FM, Poplin E, Fleming T, Leichman L (1987) Combined therapies for squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 5: 622–628Google Scholar
  19. 19.
    Al-Sarraf M (1990) The current status of combined modality treatment containing chemotherapy in patients with esophageal cancer. Int J Radiat Oncol Biol Phys 19: 813–815PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1993

Authors and Affiliations

  • Ernesto Laterza
  • Ugo S. Urso
  • Giovanni De’ Manzoni
  • Claudio Cordiano
    • 1
  1. 1.The First Department of General SurgeryUniversity of Verona—Ospedale MaggioreVeronaItaly

Personalised recommendations